Insider Transactions in Q3 2021 at Silk Road Medical Inc (SILK)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 28
2021
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
10,000
-5.19%
|
$540,000
$54.86 P/Share
|
|
Sep 28
2021
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.93%
|
$120,000
$12.15 P/Share
|
|
Sep 13
2021
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
11,000
-7.69%
|
$627,000
$57.32 P/Share
|
|
Sep 13
2021
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+7.14%
|
$11,000
$1.6 P/Share
|
|
Sep 01
2021
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,481
-2.16%
|
$382,379
$59.52 P/Share
|
|
Sep 01
2021
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,324
+2.65%
|
$31,620
$5.19 P/Share
|
|
Aug 27
2021
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
10,000
-2.63%
|
$540,000
$54.38 P/Share
|
|
Aug 27
2021
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,847
+2.95%
|
$70,164
$12.15 P/Share
|
|
Aug 27
2021
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
SELL
Open market or private sale
|
Direct |
15,407
-5.98%
|
$847,385
$55.0 P/Share
|
|
Aug 11
2021
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
11,000
-7.69%
|
$539,000
$49.12 P/Share
|
|
Aug 11
2021
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+7.14%
|
$11,000
$1.6 P/Share
|
|
Aug 02
2021
|
Andrew S. Davis Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,820
+35.54%
|
-
|
|
Aug 02
2021
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,324
-8.68%
|
$316,200
$50.75 P/Share
|
|
Aug 02
2021
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,324
+7.68%
|
$25,296
$4.73 P/Share
|
|
Jul 28
2021
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
10,000
-1.74%
|
$440,000
$44.91 P/Share
|
|
Jul 28
2021
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,616
+1.93%
|
$190,400
$25.47 P/Share
|
|
Jul 27
2021
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+1.56%
|
$3,000
$1.6 P/Share
|
|
Jul 12
2021
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
11,000
-7.69%
|
$506,000
$46.25 P/Share
|
|
Jul 12
2021
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+7.14%
|
$11,000
$1.6 P/Share
|
|
Jul 09
2021
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+2.1%
|
$4,000
$1.6 P/Share
|
|
Jul 01
2021
|
Andrew S. Davis Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
68
-0.21%
|
$3,196
$47.79 P/Share
|
|
Jul 01
2021
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,324
-16.65%
|
$303,552
$48.06 P/Share
|
|
Jul 01
2021
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,324
+14.27%
|
$25,296
$4.73 P/Share
|